Compounds > tretazicar
Page last updated: 2024-08-26

tretazicar and Breast Cancer

tretazicar has been researched along with Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Q; Kong, W; Wu, Y; Yu, B; Yu, X; Zha, X; Zhan, Y; Zhang, X; Zhang, Y1
Caraher, MC; Dunstan, MS; Leys, D; Nolan, KA; Scott, KA; Stratford, IJ1
Foygel, K; Paulmurugan, R; Sekar, TV; Willmann, JK1
Friedlos, F; Marais, R; Maycroft, KA; Paterson, H; Spooner, RA; Springer, CJ1
Clark, AJ; Cui, W; Gusterson, BA1

Other Studies

5 other study(ies) available for tretazicar and Breast Cancer

ArticleYear
Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
    Oncology reports, 2011, Volume: 26, Issue:1

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Line, Tumor; Escherichia coli; Female; Flow Cytometry; Genetic Vectors; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Simplexvirus; Telomerase; Thymidine Kinase

2011
In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:1

    Topics: Animals; Aziridines; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophages; Mice; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Quinone Reductases; RNA Interference; RNA, Small Interfering; Signal Transduction; Structure-Activity Relationship; Transcription, Genetic; Tumor Necrosis Factor-alpha

2012
Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
    Gene therapy, 2013, Volume: 20, Issue:5

    Topics: Animals; Apoptosis; Aziridines; Breast Neoplasms; Cell Line, Tumor; Escherichia coli; Escherichia coli Proteins; Ganciclovir; Genes, Reporter; Genetic Therapy; Humans; Mice; Nitroreductases; Prodrugs; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Transplantation, Heterologous

2013
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapy.
    International journal of cancer, 2001, Jul-01, Volume: 93, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Base Sequence; Breast Neoplasms; Cell Survival; Cloning, Molecular; Dimerization; Enzyme Activation; Escherichia coli; Female; Genetic Therapy; Humans; Molecular Sequence Data; Nitroreductases; Prodrugs; Recombinant Proteins; Restriction Mapping; Transfection; Tumor Cells, Cultured

2001
Inhibition of myc-dependent breast tumor formation in transgenic mice.
    Breast cancer research and treatment, 2002, Volume: 71, Issue:1

    Topics: Animals; Aziridines; Breast Neoplasms; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Genetic Therapy; Lactation; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Nitroreductases; Prodrugs

2002